ABCB1 and cancer: PCI of protein toxins has previously been shown to circumvent resistance mediated through increased expression of P-glycoprotein [43,44] and the present results in the HT-29/SR cells further documents this strategy as highly efficient for the treatment of therapy resistant cancer.